Immediate Impact
58 standout
Citing Papers
Cancer associated fibroblasts in cancer development and therapy
2025 Standout
Datopotamab Deruxtecan in Advanced or Metastatic HR+/HER2– and Triple-Negative Breast Cancer: Results From the Phase I TROPION-PanTumor01 Study
2024 Standout
Works of D. Xing being referenced
Abstract PD6-13: Phase 1b/2 study to evaluate eribulin mesylate in combination with pembrolizumab in patients with metastatic triple-negative breast cancer
2018
Early results from an open-label phase 1b/II study of eribulin mesylate (EM) + pegvorhyaluronidase alfa (PEGHP20) combination for the treatment of patients with HER2-negative, high-hyaluronan (HA) metastatic breast cancer (MBC)
2018
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| D. Xing | 102 | 232 | 50 | 278 | 170 | 10 | 442 | |
| Hill Cs | 125 | 141 | 41 | 345 | 69 | 10 | 499 | |
| Hickey Rc | 117 | 116 | 41 | 282 | 76 | 13 | 397 | |
| Margareta Telenius‐Berg | 87 | 147 | 18 | 272 | 65 | 14 | 429 | |
| Kathy Liu | 29 | 190 | 13 | 113 | 104 | 15 | 408 | |
| Sylvie Beaudenon‐Huibregtse | 38 | 129 | 21 | 402 | 134 | 9 | 458 | |
| B.B. Jacobsen | 76 | 90 | 17 | 103 | 143 | 9 | 379 | |
| Ruth E. Farrell | 106 | 140 | 15 | 343 | 36 | 8 | 457 | |
| Usha Sriram | 164 | 53 | 25 | 103 | 159 | 12 | 421 | |
| Yedatore Venkatesh | 116 | 107 | 23 | 275 | 96 | 10 | 382 | |
| Annalisa Montanaro | 43 | 201 | 22 | 419 | 109 | 8 | 500 |
All Works
Loading papers...